Search - tctmd.com

Displaying 181 - 200 of 697

Sort: Relevancy | Date

News Daily News

LDL Cholesterol Control Post-PCI Is Low and Linked to Worse Outcomes

Yael L. Maxwell

September 14, 2020

News Conference News ESC 2020

In Long-term, Real-world Data, CABG Bests PCI for Diabetic Patients With MVD

Yael L. Maxwell

September 01, 2020

News Conference News ESC 2020

Revascularization Benefits ISCHEMIA Patients With Mild LV Dysfunction or HF

Michael O'Riordan

August 31, 2020

News Daily News

Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI

L.A. McKeown

August 10, 2020

News Daily News

Thrombus Burden Greater in STEMI Patients With COVID-19

Michael O'Riordan

July 20, 2020

News Daily News

Women With Acute MI Fare Worse Than Men After PCI or CABG

L.A. McKeown

July 15, 2020

News Daily News

Polymer-Free DES Hold No Long-term Advantage: ISAR-TEST-5

Michael O'Riordan

July 07, 2020

News Conference News EuroPCR 2020

Tirofiban Provides Better Platelet Inhibition Than Cangrelor in STEMI Patients

Michael O'Riordan

June 30, 2020

News

Drug-Coated Balloons for CAD: Some International Consensus

L.A. McKeown

May 27, 2020

News Features

Hospitals Plan Cautious Restart to Elective Procedures as COVID-19 Wanes

Michael O'Riordan

May 12, 2020

Presentation

Clopidogrel vs Ticagrelor or Prasugrel in Patients 70 Years or Older With NTSE ACS: POPular Age

April 27, 2020

News Daily News

Clopidogrel Holds Advantage in Older NTSE ACS Patients: POPular AGE Published

Michael O'Riordan

April 27, 2020

News Daily News

Functionally Significant Nonculprit Lesions Pose Risk in STEMI Patients

Michael O'Riordan

April 21, 2020

News

As COVID-19 Spreads, US Cath Labs Ponder Fibrinolytics for STEMI

Michael O'Riordan

April 17, 2020

Presentation

Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI

April 15, 2020

News Daily News

Smoker’s Paradox Debunked: Post-STEMI Outcomes Worse in Cigarette Smokers

Michael O'Riordan

April 15, 2020

News Features

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

Michael O'Riordan

April 07, 2020

News Conference News ACC 2020

TICO: Ticagrelor Monotherapy After 3 Months of DAPT Curbs Bleeding in Stented ACS Patients

Todd Neale

March 31, 2020

Presentation ACC 2020

Ticagrelor With or Without Aspirin in Acute Coronary Syndrome After PCI: Randomized Evaluation Of Ticagrelor Monotherapy After 3- month Dual-antiplatelet Therapy In Acute Coronary Syndrome The TICO trial

Presenter: Yangsoo Jang

March 30, 2020

News Daily News

Who Should Head to the Cath Lab in the COVID-19 Pandemic?

Michael O'Riordan

March 26, 2020

Advertisement

LDL Cholesterol Control Post-PCI Is Low and Linked to Worse Outcomes

In Long-term, Real-world Data, CABG Bests PCI for Diabetic Patients With MVD

Revascularization Benefits ISCHEMIA Patients With Mild LV Dysfunction or HF

Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI

Thrombus Burden Greater in STEMI Patients With COVID-19

Women With Acute MI Fare Worse Than Men After PCI or CABG

Polymer-Free DES Hold No Long-term Advantage: ISAR-TEST-5

Tirofiban Provides Better Platelet Inhibition Than Cangrelor in STEMI Patients

Drug-Coated Balloons for CAD: Some International Consensus

Hospitals Plan Cautious Restart to Elective Procedures as COVID-19 Wanes

Clopidogrel vs Ticagrelor or Prasugrel in Patients 70 Years or Older With NTSE ACS: POPular Age

Clopidogrel Holds Advantage in Older NTSE ACS Patients: POPular AGE Published

Functionally Significant Nonculprit Lesions Pose Risk in STEMI Patients

As COVID-19 Spreads, US Cath Labs Ponder Fibrinolytics for STEMI

Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI

Smoker’s Paradox Debunked: Post-STEMI Outcomes Worse in Cigarette Smokers

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

TICO: Ticagrelor Monotherapy After 3 Months of DAPT Curbs Bleeding in Stented ACS Patients

Ticagrelor With or Without Aspirin in Acute Coronary Syndrome After PCI: Randomized Evaluation Of Ticagrelor Monotherapy After 3- month Dual-antiplatelet Therapy In Acute Coronary Syndrome The TICO trial

Who Should Head to the Cath Lab in the COVID-19 Pandemic?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content